Similarly, overexpression of YWHAZ is a prognostic biomarker for breast tumors and ovarian cancer, and a reduction in YWHAE levels has been seen in gastric carcinogenesis [61,62,63]. This evidence concerns the gene YWHAE and ovarian cancer.